UAE Antibody Production Market Size & Outlook, 2022-2030
UAE antibody production market, 2018-2030 (US$M)
Related Markets
UAE antibody production market highlights
- The UAE antibody production market generated a revenue of USD 98.5 million in 2022 and is expected to reach USD 302.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 15.1% from 2023 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2022.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Antibody production market data book summary
| Market revenue in 2022 | USD 98.5 million |
| Market revenue in 2030 | USD 302.6 million |
| Growth rate | 15.1% (CAGR from 2022 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Instruments, Consumables |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, PerkinElmer, ProPhase Labs Inc, Azenta Inc, Macrogenics Inc |
Other key industry trends
- In terms of revenue, UAE accounted for 0.6% of the global antibody production market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa antibody production market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 302.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibody Production Market Scope
Antibody Production Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE antibody production market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibody production market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 55.94% in 2022. Horizon Databook has segmented the UAE antibody production market based on software, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
- UAE Antibody Production Product Outlook (Revenue, USD Million, 2018-2030)
- Software
- Instruments
- Chromatography Systems
- Filtration Systems
- Bioreactors
- Multi-use Bioreactors
- Single-use Bioreactors
- Consumables
- Media
- Buffers & Reagents
- Chromatography Resins
- Filtration Consumables
- Others
- UAE Antibody Production Process Outlook (Revenue, USD Million, 2018-2030)
- Upstream Processing
- Downstream Processing
- UAE Antibody Production Type Outlook (Revenue, USD Million, 2018-2030)
- Polyclonal Antibody
- Monoclonal Antibody
- UAE Antibody Production End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- CROs and CDMOs
Reasons to subscribe to UAE antibody production market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE antibody production market databook
-
Our clientele includes a mix of antibody production market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE antibody production market, including forecasts for subscribers. This country databook contains high-level insights into UAE antibody production market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE antibody production market size, by product, 2018-2030 (US$M)
UAE Antibody Production Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
